These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31005631)
1. Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas. Lewis R; Li YD; Hoffman L; Hashizume R; Gravohac G; Rice G; Wadhwani NR; Jie C; Pundy T; Mania-Farnell B; Mayanil CS; Soares MB; Lei T; James CD; Foreman NK; Tomita T; Xi G Neoplasia; 2019 Jun; 21(6):505-515. PubMed ID: 31005631 [TBL] [Abstract][Full Text] [Related]
2. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods. de Sousa GR; Lira RCP; de Almeida Magalhães T; da Silva KR; Nagano LFP; Saggioro FP; Baroni M; Marie SKN; Oba-Shinjo SM; Brandelise S; de Paula Queiroz RG; Brassesco MS; Scrideli CA; Tone LG; Valera ET J Mol Med (Berl); 2021 Aug; 99(8):1101-1113. PubMed ID: 33903940 [TBL] [Abstract][Full Text] [Related]
3. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome. Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma. Shu C; Wang Q; Yan X; Wang J Clin Transl Oncol; 2018 Nov; 20(11):1439-1447. PubMed ID: 29704232 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Mack SC; Pajtler KW; Chavez L; Okonechnikov K; Bertrand KC; Wang X; Erkek S; Federation A; Song A; Lee C; Wang X; McDonald L; Morrow JJ; Saiakhova A; Sin-Chan P; Wu Q; Michaelraj KA; Miller TE; Hubert CG; Ryzhova M; Garzia L; Donovan L; Dombrowski S; Factor DC; Luu B; Valentim CLL; Gimple RC; Morton A; Kim L; Prager BC; Lee JJY; Wu X; Zuccaro J; Thompson Y; Holgado BL; Reimand J; Ke SQ; Tropper A; Lai S; Vijayarajah S; Doan S; Mahadev V; Miñan AF; Gröbner SN; Lienhard M; Zapatka M; Huang Z; Aldape KD; Carcaboso AM; Houghton PJ; Keir ST; Milde T; Witt H; Li Y; Li CJ; Bian XW; Jones DTW; Scott I; Singh SK; Huang A; Dirks PB; Bouffet E; Bradner JE; Ramaswamy V; Jabado N; Rutka JT; Northcott PA; Lupien M; Lichter P; Korshunov A; Scacheri PC; Pfister SM; Kool M; Taylor MD; Rich JN Nature; 2018 Jan; 553(7686):101-105. PubMed ID: 29258295 [TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis. Malgulwar PB; Nambirajan A; Pathak P; Rajeshwari M; Suri V; Sarkar C; Singh M; Sharma MC Hum Pathol; 2018 Dec; 82():149-157. PubMed ID: 30067950 [TBL] [Abstract][Full Text] [Related]
7. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150 [TBL] [Abstract][Full Text] [Related]
8. H3 K27M mutations are extremely rare in posterior fossa group A ependymoma. Ryall S; Guzman M; Elbabaa SK; Luu B; Mack SC; Zapotocky M; Taylor MD; Hawkins C; Ramaswamy V Childs Nerv Syst; 2017 Jul; 33(7):1047-1051. PubMed ID: 28623522 [TBL] [Abstract][Full Text] [Related]
9. Genes upregulated in the amnion at labour are bivalently marked by activating and repressive histone modifications. Mitchell CM; Hirst JJ; Mitchell MD; Murray HG; Zakar T Mol Hum Reprod; 2019 Apr; 25(4):228-240. PubMed ID: 30753586 [TBL] [Abstract][Full Text] [Related]
10. Setd1a Plays Pivotal Roles for the Survival and Proliferation of Retinal Progenitors via Histone Modifications of Uhrf1. Deng X; Iwagawa T; Fukushima M; Suzuki Y; Watanabe S Invest Ophthalmol Vis Sci; 2021 May; 62(6):1. PubMed ID: 33938913 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade? Nambirajan A; Malgulwar PB; Sharma A; Boorgula MT; Doddamani R; Singh M; Suri V; Sarkar C; Sharma MC Brain Tumor Pathol; 2019 Oct; 36(4):152-161. PubMed ID: 31388782 [TBL] [Abstract][Full Text] [Related]
12. WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. Wadhwani N; Nayak S; Wang Y; Hashizume R; Jie C; Mania-Farnell B; James CD; Xi G; Tomita T Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444539 [TBL] [Abstract][Full Text] [Related]